id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-D-4634-0002,FDA,FDA-2025-D-4634,Monoclonal Antibodies: Streamlined Nonclinical Safety Studies Guidance for Industry Draft Guidance,Other,Guidance,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,2026-02-03T04:59:59Z,2026-02-26T10:00:14Z,,1,0,09000064b90a9867
FDA-2025-D-4634-0001,FDA,FDA-2025-D-4634,Monoclonal Antibodies: Streamlined Nonclinical Safety Studies; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,,2025-12-03T19:23:31Z,2025-21864,0,0,09000064b90abea8